Total Payments
$325,315
2024 Payments
$37,726
Companies
46
Transactions
817
Medicare Patients
1,358
Medicare Billing
$162,188
Payment Breakdown by Category
Other$254,194 (78.1%)
Travel$52,168 (16.0%)
Food & Beverage$15,302 (4.7%)
Consulting$3,428 (1.1%)
Education$223.39 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $132,614 | 50 | 40.8% |
| Honoraria | $121,580 | 42 | 37.4% |
| Travel and Lodging | $52,168 | 211 | 16.0% |
| Food and Beverage | $15,302 | 498 | 4.7% |
| Consulting Fee | $3,428 | 6 | 1.1% |
| Education | $223.39 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $251,716 | 384 | $0 (2024) |
| ARGENX US, INC. | $59,870 | 81 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $3,562 | 67 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $934.32 | 30 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $867.97 | 17 | $0 (2024) |
| Abbott Laboratories | $853.90 | 8 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $678.13 | 19 | $0 (2024) |
| GENZYME CORPORATION | $600.20 | 11 | $0 (2023) |
| UCB, Inc. | $552.52 | 33 | $0 (2024) |
| EMD Serono, Inc. | $534.22 | 20 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,726 | 78 | ARGENX US, INC. ($30,472) |
| 2023 | $25,471 | 59 | ARGENX US, INC. ($22,766) |
| 2022 | $95,879 | 165 | CSL Behring ($88,376) |
| 2021 | $1,703 | 47 | CSL Behring ($412.32) |
| 2020 | $7,125 | 39 | CSL Behring ($5,761) |
| 2019 | $108,660 | 225 | CSL Behring ($104,739) |
| 2018 | $46,504 | 142 | CSL Behring ($44,604) |
| 2017 | $2,247 | 62 | Avanir Pharmaceuticals, Inc. ($352.78) |
All Payment Transactions
817 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $171.10 | General |
| Category: Neurology | ||||||
| 12/03/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $57.24 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $554.76 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: Neurology | ||||||
| 10/30/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $352.95 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $172.50 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $114.47 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $98.66 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $80.00 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $26.00 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Neurology | ||||||
| 10/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | CSL Behring | Hizentra (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: Immunology | ||||||
| 10/07/2024 | CSL Behring | Hizentra (Biological) | Travel and Lodging | Cash or cash equivalent | $439.52 | General |
| Category: Immunology | ||||||
| 10/07/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Immunology | ||||||
| 10/07/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | Cash or cash equivalent | $8.50 | General |
| Category: Immunology | ||||||
| 10/02/2024 | CSL Behring | Hizentra (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $625.00 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Rare Disease | ||||||
| 09/24/2024 | ARGENX US, INC. | VYVGART (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,500.00 | General |
| Category: Immunology | ||||||
| 09/24/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $123.25 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 345 | 483 | $87,790 | $42,469 |
| 2022 | 4 | 323 | 467 | $81,325 | $40,078 |
| 2021 | 4 | 324 | 465 | $76,305 | $40,712 |
| 2020 | 6 | 366 | 493 | $77,470 | $38,930 |
Total Patients
1,358
Total Services
1,908
Medicare Billing
$162,188
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 185 | 322 | $34,540 | $20,820 | 60.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 95 | 95 | $26,125 | $14,739 | 56.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 21 | 21 | $12,600 | $3,512 | 27.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 44 | 45 | $14,525 | $3,398 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 177 | 317 | $31,700 | $19,552 | 61.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 83 | 83 | $22,825 | $13,511 | 59.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 44 | 48 | $15,600 | $3,699 | 23.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 19 | 19 | $11,200 | $3,316 | 29.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 186 | 327 | $30,730 | $20,706 | 67.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 86 | 86 | $23,350 | $13,846 | 59.3% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 19 | 19 | $11,500 | $3,496 | 30.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 33 | 33 | $10,725 | $2,664 | 24.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 198 | 321 | $25,680 | $17,092 | 66.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 82 | 82 | $21,875 | $12,668 | 57.9% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2020 | 18 | 18 | $10,800 | $3,187 | 29.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 35 | 35 | $11,375 | $2,758 | 24.2% |
| 95957 | Digital analysis of electrical brain wave activity (eeg) | Office | 2020 | 11 | 11 | $6,050 | $2,283 | 37.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 22 | 26 | $1,690 | $942.31 | 55.8% |
About Dr. Albert Cook, MD
Dr. Albert Cook, MD is a Neurology healthcare provider based in Johns Creek, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891729430.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Cook, MD has received a total of $325,315 in payments from pharmaceutical and medical device companies, with $37,726 received in 2024. These payments were reported across 817 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($132,614).
As a Medicare-enrolled provider, Cook has provided services to 1,358 Medicare beneficiaries, totaling 1,908 services with total Medicare billing of $162,188. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Johns Creek, GA
- Active Since 07/10/2006
- Last Updated 04/24/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891729430
Products in Payments
- Hizentra (Biological) $251,697
- VYVGART (Drug) $44,200
- VYVGART HYTRULO (Drug) $15,671
- AIMOVIG (Biological) $2,786
- APTIOM (Drug) $876.19
- Neuromodulation Dspsbls and Accs (Device) $470.86
- TYSABRI (Biological) $450.00
- Gamunex-C (Biological) $422.42
- UBRELVY (Drug) $411.54
- ZEPOSIA (Drug) $396.71
- Infinity DBS Pulse Generators (Device) $383.04
- ULTOMIRIS (Biological) $369.47
- AUBAGIO (Drug) $365.05
- KESIMPTA (Drug) $300.65
- Mavenclad (Biological) $298.04
- Aimovig (Biological) $295.28
- GILENYA (Drug) $289.40
- Briviact (Drug) $260.56
- INGREZZA (Drug) $245.86
- AUSTEDO (Drug) $224.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.